About Injecto Capta
Injecto Capta is a company based in Secunderabad (India). The company has 4 employees. Injecto Capta offers products and services including Tablets and Capsules and Injectables.
- Headquarter Secunderabad, India
- Employees 4
- SectorsHealthcare
- Email••••••••
- Legal Name Injecto Capta Private Limited
- Date of Incorporation 20 Mar, 1992
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹3.80 Cr
FY 2019 · -2% YoY
- Net Profit₹11.2 Lakh
FY 2019 · 3% margin
- EBITDA₹22.6 Lakh
FY 2019 · 6% margin
- Employee Count4
Associated legal entities of Injecto Capta
Injecto Capta operates through Injecto Capta Private Limited (amalgamated). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2019) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Injecto Capta Private Limited CIN U67120TG1992PTC014011 | Amalgamated | 20 Mar 1992 | Hyderabad, Telangana | ₹3.8 Cr | 4 | 2 | View details |
Products & Services of Injecto Capta
Injecto Capta offers a comprehensive portfolio of products and services, including Tablets and Capsules and Injectables.
Tablets and capsules are manufactured and distributed for medicinal purposes
Injectables are produced for therapeutic applications in healthcare settings
Board of directors of Injecto Capta Private Limited (Injecto Capta)
Injecto Capta Private Limited is the primary company behind Injecto Capta. The board of Injecto Capta Private Limited currently have 2 directors; the longest-serving is Divita Gulati, appointed in 2012. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Divita Gulati DIN 00082034 | Director | 26 May 2012 | 14 yrs 4 mo | Injecto Capta Private Limited |
| Sunil Gulati DIN 01463670 | Director | 08 Aug 2012 | 14 yrs 2 mo | Injecto Capta Private Limited |
Financials of Injecto Capta
Figures of Injecto Capta Private Limited, the primary company behind Injecto Capta, for FY 2019. Revenue was ₹3.80 Cr (-2% year on year). Net profit was ₹11.2 Lakh (3% margin). EBITDA was ₹22.6 Lakh (6% margin). Revenue has grown at a compounded annual rate of -3% over three years and -2% over five years.
- ₹3.80 CrRevenue · FY 2019 · -2% YoY
- ₹11.2 LakhNet profit · 3% margin
- ₹22.6 LakhEBITDA · 6% margin
- ₹18.2 LakhPaid-up capital
- 4Employees (provident fund records)
- -3%Revenue CAGR, 3 years
- -2%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Injecto Capta Private Limited are on its company page.
Detailed financial statements for Injecto Capta
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Injecto Capta
10 companies that operate in the same segment as Injecto Capta (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Injecto Capta
Injecto Capta is headquartered in Secunderabad, India. It is registered at Secunderabad, Telangana, India.
Injecto Capta has 4 employees.
The primary company behind Injecto Capta, Injecto Capta Private Limited, reported revenue of ₹3.80 Cr for FY 2019, down 2% year on year.
Injecto Capta was established in 1991 and is certified under ISO 9001:2015 as a PCD Pharma Franchise Company. A variety of products, such as tablets, capsules, dry syrups, liquid orals, ointments, injectables, and Ayurvedic supplements, are offered by the company. It is managed by Mr. Sunil G., who brings extensive experience from sectors including pharmaceuticals, engineering, and software in India and the U.S.A. Business enquiries are facilitated through dedicated sales contacts. The companys operations are based in Hyderabad, India, with an international presence in New York, USA, emphasizing quality and distribution in the healthcare field.
Injecto Capta offers Tablets and Capsules and Injectables.
Injecto Capta operates through Injecto Capta Private Limited.
The legal entities of Injecto Capta currently have 2 directors, including Sunil Gulati, Divita Gulati.